(Approval lapsed) INHIXA enoxaparin 40mg/0.4mL solution for injection pre-filled syringe with needle guard (UK)
Section 19A approved medicine
(Approval lapsed) INHIXA enoxaparin 40mg/0.4mL solution for injection pre-filled syringe with needle guard (UK)
Section 19A approval holder
Orspec Pharma Pty Ltd ABN 15 634 980 417
Phone
02 43394239
Approved until
Status
Expired
Medicines in short supply/unavailable
CLEXANE enoxaparin sodium 40mg/0.4mL injection syringe with automatic safety lock system - ARTG 221718
Indication(s)
- Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
- Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
- Prevention of thrombosis in extra-corporeal circulation during haemodialysis.
- Treatment of established deep vein thrombosis.
- Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
- Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).